title: Familial Mediterranean fever presenting with pulmonary embolism.
abstract: Familial Mediterranean fever (FMF) is the autoinflammatory disease and hereditary periodic fever syndrome that most commonly affects people of Eastern Mediterranean origin. It is characterized by recurrent self-limited attacks of fever and serositis, with an increase in acute-phase reactant markers, and is transmitted in an autosomal recessive pattern. Inflammation shifts the hemostatic mechanisms favoring thrombosis. There are few reports of an increased risk of hypercoagulability in patients with FMF in the absence of amyloidosis and nephrotic syndrome. In this case report, we describe a 43-year-old Turkish patient who presented with right-sided pleuritic chest pain and pulmonary embolism. The patient described having prior similar attacks of serositis, but had never been diagnosed with FMF. Further workup revealed an increase in acute phase reactants, negative hypercoagulability studies and heterozygosity for the M694V mutation in the pyrin (MEFV) gene. We identified untreated FMF and chronic inflammation as his only risk factor for pulmonary embolism. With this case report, we support recent studies that have demonstrated that inflammation may lead to prothrombotic states in patients with FMF.
authors.affiliation: University of Connecticut Heath Center, Department of Medicine. 230 Farmington Avenue, Farmington, CT 06030-1235, USA. xruiz@resident.uchc.edu
authors.forename: Ximena D
authors.initials: XD
authors.lastname: Ruiz
authors.forename: Carlos M
authors.initials: CM
authors.lastname: Gadea
mesh_terms: D000082:Acetaminophen / Q000627:therapeutic use; D000328:Adult; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D002637:Chest Pain / Q000188:drug therapy / Q000209:etiology; D003078:Colchicine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D010505:Familial Mediterranean Fever / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005500:Follow-Up Studies; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011655:Pulmonary Embolism / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D012700:Serositis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D050257:Tubulin Modulators / Q000627:therapeutic use; D014421:Turkey; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D018712:Analgesics, Non-Narcotic; D000925:Anticoagulants; D050257:Tubulin Modulators; D000082:Acetaminophen; D014859:Warfarin; D006493:Heparin; D003078:Colchicine